Skip to main content
. 2021 Apr 9;13(4):525. doi: 10.3390/pharmaceutics13040525

Figure 2.

Figure 2

Clinical trials of NK-cell-based cancer therapy. A large number of NK cell clinical trials have been studied, and some remarkable studies in hematologic cancers (A) and solid tumors (B) were selected.